Mymetics Corporation
MYMX · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 108.11 | -52.11 | 13,032.83 | -7,072.40 |
| FCF Yield | -0.01% | -0.01% | -0.00% | -0.00% |
| EV / EBITDA | -8,589.18 | -9,029.25 | -27,465.64 | -14,733.34 |
| Quality | ||||
| ROIC | -24.57% | -21.75% | -19.61% | -18.23% |
| Gross Margin | -47,966.67% | -32,400.00% | -2,914.29% | -773.87% |
| Cash Conversion Ratio | 0.35 | 0.36 | 0.41 | 0.23 |
| Growth | ||||
| Revenue 3-Year CAGR | -55.91% | -69.99% | -22.43% | -18.09% |
| Free Cash Flow Growth | 1.11% | 0.12% | -69.64% | 56.42% |
| Safety | ||||
| Net Debt / EBITDA | -36.02 | -34.23 | -43.50 | -39.45 |
| Interest Coverage | -0.62 | -0.60 | -0.58 | -0.52 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 7,489.42 | 1,807.41 | 716.21 | 443.56 |